Pfetin predicts outcome for patients with gastrointestinal stromal tumors

Pfetin predicts outcome for patients with gastrointestinal stromal tumors

Play all audios:

Loading...

Suehara Y et al. (2008) Pfetin as a prognostic biomarker of gastrointestinal stromal tumors revealed by proteomics. Clin Cancer Res 14: 1707–1717The molecular background of gastrointestinal stromal tumors (GISTs) has been investigated through genome and transcriptome studies, but the proteomic profile of these tumors has not yet been established. Suehara et al. conducted a quantitative expression study of intact proteins in GIST samples to investigate this profile and determined that decreased expression of pfetin predicts poor outcome in patients with these tumors.Anyone you share the following link with will be able to read this content:

Suehara Y et al. (2008) Pfetin as a prognostic biomarker of gastrointestinal stromal tumors revealed by proteomics. Clin Cancer Res 14: 1707–1717


The molecular background of gastrointestinal stromal tumors (GISTs) has been investigated through genome and transcriptome studies, but the proteomic profile of these tumors has not yet been


established. Suehara et al. conducted a quantitative expression study of intact proteins in GIST samples to investigate this profile and determined that decreased expression of pfetin


predicts poor outcome in patients with these tumors.


Anyone you share the following link with will be able to read this content: